Cargando…
Hepatocellular Carcinoma Prevention by Aspirin: Are Platelets the Link?
Autores principales: | Nischalke, Hans Dieter, Klüners, Alexandra, Nattermann, Jacob, Berg, Thomas, Strassburg, Christian P., Lutz, Philipp |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8631088/ https://www.ncbi.nlm.nih.gov/pubmed/34558827 http://dx.doi.org/10.1002/hep4.1769 |
Ejemplares similares
-
Genetic Variation of SAMM50 Is Not an Independent Risk Factor for Alcoholic Hepatocellular Carcinoma in Caucasian Patients
por: Nischalke, Hans Dieter, et al.
Publicado: (2022) -
High producer variant of lipoprotein lipase may protect from hepatocellular carcinoma in alcohol-associated cirrhosis
por: Schmalz, Franziska, et al.
Publicado: (2023) -
Impact of Rifaximin on the Frequency and Characteristics of Spontaneous Bacterial Peritonitis in Patients with Liver Cirrhosis and Ascites
por: Lutz, Philipp, et al.
Publicado: (2014) -
IL-28B Genetic Variants Determine the Extent of Monocyte-Induced Activation of NK Cells in Hepatitis C
por: Krämer, Benjamin, et al.
Publicado: (2016) -
TRAIL receptor I (DR4) polymorphisms C626G and A683C are associated with an increased risk for hepatocellular carcinoma (HCC) in HCV-infected patients
por: Körner, Christian, et al.
Publicado: (2012)